Your session is about to expire
← Back to Search
Liraglutide for Childhood Obesity
Study Summary
This trial is testing whether liraglutide helps children with obesity lose weight. Children will be randomly assigned to receive either liraglutide or a placebo, and researchers will track how much weight the children lose and if there are any side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 100 Patients • NCT02014740Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My obesity is caused by a specific medical condition.I haven't taken obesity medication in the last 90 days.I have Type 1 diabetes.I am at any stage of puberty.My HbA1c level is 10.0% or lower.I am between 6 and 11 years old.My BMI is in the top 5% for my age and gender.
- Group 1: Placebo
- Group 2: Liraglutide 3.0 mg
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people total will be participating in this research project?
"Obesity clinical trials are currently recruiting 998 participants while Liraglutide clinical trials are actively enrolling 36 patients. This particular study, however, is not presently looking for volunteers. The trial was initially posted on 3/4/2021 and last updated on 11/10/2022."
Could you explain the risks associated with taking Liraglutide?
"Liraglutide is considered safe, as it has received a score of 3. This is due to the fact that this medication has entered Phase 3 clinical trials, meaning there is significant data supporting its efficacy and safety."
What are some of the main conditions that Liraglutide has been known to improve?
"Patients that commonly use liraglutide do so as part of an exercise regime. However, this medication can also help those who have unsuccessfully tried monotherapy and those suffering from cardiovascular disease or risks thereof."
Are there any available appointments for this research program?
"The latest information available on clinicaltrials.gov indicates that this study is not recruiting patients at the moment. The listing was first posted on March 4th, 2021 and updated November 10th, 2022. While subjects are not being recruited for this trial, there are 1,034 other studies currently looking for volunteers."
How can I join this clinical trial?
"The current recruitment goal for this clinical trial is 78 children, aged 6 to 12 years old, that suffer from obesity. To qualify, patients must meet the following body mass index criteria: their BMI must be equal to or greater than the 95th percentile when compared against gender and age-specific growth charts (CDC.gov)."
Are there other examples of drugs similar to Liraglutide that have been trialed?
"UBMD Pediatrics, Division of Pediatric Endocrinology first studied liraglutide in 2012. Since then, a total of 18519 completed studies have been conducted worldwide. There are currently 36 clinical trials recruiting patients actively, with many of these taking place in Dayton, Ohio."
How many staff members are managing this clinical trial today?
"Patients are encouraged to select the clinical trial site nearest them to minimize travel as this study is being conducted at 7 different locations. The sites are situated in cities including Dayton, Pittsburgh and Baton Rouge among others."
Are elderly patients within the age limit for this experiment?
"The pool of potential participants for this clinical trial must, at a minimum, be 6 years old but not older than 12."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger